This Government Contract opportunity from Department Of Health And Human Services was posted on September 1, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
ARIS HiQ Instrument
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institute of Health intends to award a firm-fixed-price, sole-source follow-on reagent rental agreement to Remel, Inc., a subsidiary of Thermo Fisher Scientific, for the ARIS HiQ Instrument and associated SWIN Computer System. This acquisition, identified under solicitation number 26-007626, is designed to provide the Department of Laboratory Medicine's Microbiology Service with continued access to instrumentation, susceptibility testing panels, reagents, consumables, and comprehensive technical and maintenance support. The estimated value of the contract is 276,000 dollars, structured with a base year and two option years. The primary objective of this agreement is to ensure uninterrupted antimicrobial susceptibility testing for bacterial, fungal, and mycobacterial isolates across the Bacteriology, Mycology, and Mycobacteriology laboratory sections. Because the ARIS HiQ platform is already integrated into the laboratory's quality management systems and the Laboratory Information System, maintaining this specific platform is critical for patient care, clinical research, and antimicrobial stewardship at the NIH Clinical Center. Remel, Inc. has been identified as the only source capable of meeting these requirements, as other market searches yielded no viable alternatives that could support the existing validated testing environment.
General Info
Agency
NAICS
Place of Performance
MD, 20892, USASet-Aside
Documents
(1)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Submission Closed
Organization & Contact Information
Full Description
The National Institute of Health (NIH) intends to negotiate and award a purchase order without providing for full and open competition to REMEL, INC. The purpose of this requirement is to provide a firm-fixed-price contract for the Remel ARIS HiQ Instrument and associated SWIN Computer System in the Department of Laboratory Medicine (DLM).
The purpose of this acquisition is to establish a follow-on reagent rental agreement with Remel, Inc. for the ARIS HiQ Instrument and associated SWIN Computer System utilized by the Department of Laboratory Medicine (DLM), Microbiology Service, to perform antimicrobial susceptibility testing (AST).
The agreement will provide continued access to the existing instrumentation, susceptibility testing panels, reagents, consumables, supplies, software support, technical support, preventative maintenance, corrective maintenance, and applications support necessary to sustain routine AST operations. The agreement will also provide manufacturer-authorized support services required to maintain operational functionality and performance of the ARIS HiQ platform.
The primary objective of this acquisition is to ensure uninterrupted antimicrobial susceptibility testing services across the Bacteriology, Mycology, and Mycobacteriology laboratory sections of the Microbiology Service. Continued operation of the ARIS HiQ platform supports patient care, clinical research protocols, infection prevention activities, and antimicrobial stewardship efforts at the NIH Clinical Center.
The Microbiology Service in the DLM requires continuation of an existing reagent rental agreement with Remel, Inc., a subsidiary of Thermo Fisher Scientific, for the ARIS HiQ Instrument and associated SWIN Computer System currently utilized for antimicrobial susceptibility testing (AST). The reagent rental agreement shall provide continued access to instrumentation, reagents, consumables, supplies, technical support, and preventative maintenance necessary to support routine clinical testing operations.
The ARIS HiQ platform is used for antimicrobial susceptibility testing of bacterial, fungal, and mycobacterial isolates recovered from clinical specimens submitted to the Microbiology Service. The platform supports testing performed within the Bacteriology,
Mycology and Mycobacteriology sections and are an established component of the Department's testing algorithm.
In addition, the Laboratory Information System (LIS) has been configured to support testing performed on the ARIS HiQ platform, including test setup, result reporting, interpretive comments, and associated workflow processes. The current testing environment has been established to support efficient and reliable reporting of antimicrobial susceptibility results in accordance with laboratory and regulatory requirements.
The current testing environment supports efficient and reliable antimicrobial susceptibility testing and has been incorporated into the laboratory's routine clinical operations, quality management systems, and reporting processes.
Finally, a review of the GSA Advantage, Dynamic Small Business Search, and previous government acquisitions returned no results that meet all the requirements. Therefore, only REMEL, INC. is capable of meeting the needs of this requirement.
More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
